Ticagrelor
Concept
Vocabulary Service
Overview
subject area of
-
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction Academic Article
-
A practical approach to prescribing antiplatelet therapy in patients with acute coronary syndromes Academic Article
-
Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers Academic Article
-
Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers Academic Article
-
Antiplatelet Therapy and Cardiac Surgery: Review of Recent Evidence and Clinical Implications Academic Article
-
Antithrombotic drug removal from whole blood using Haemoadsorption with a porous polymer bead sorbent Academic Article
-
Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTudy (COAPT) Academic Article
-
Contemporary Management of ST-Elevation Myocardial Infarction Academic Article
-
Determining the price for pharmaceuticals in Germany: comparing a shortcut for IQWiG's efficiency frontier method with the price set by the manufacturer for ticagrelor Academic Article
-
Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention Academic Article
-
Effects of ticagrelor versus clopidogrel on platelet function in fibrinolytic-treated STEMI patients undergoing early PCI Academic Article
-
Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy Academic Article
-
Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromes Academic Article
-
In ACS with planned invasive evaluation, prasugrel vs ticagrelor reduced a composite of death, MI, or stroke at 1 y Academic Article
-
In Vitro Reversal of the Anti-Aggregant Effect of Ticagrelor Using Untreated Platelets Academic Article
-
In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding Academic Article
-
Long-term pharmacodynamic effects of Ticagrelor versus Clopidogrel in fibrinolytic-treated STEMI patients undergoing early PCI Academic Article
-
Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudy Academic Article
-
New antithrombotic agents—insights from clinical trials Academic Article
-
Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial Academic Article
-
Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future Academic Article
-
Platelet Transfusion for Ticagrelor Reversal Academic Article
-
Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study Academic Article
-
Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies Academic Article
-
Reversal of the antiplatelet effect of ticagrelor by simulated platelet transfusion Academic Article
-
Role of phenotypic and genetic testing in managing clopidogrel therapy Academic Article
-
The Value of Large Randomized Trials of Two Active Interventions to Define the Optimal Treatment in Patients With Acute Coronary Syndrome Academic Article
-
There seems to be a low risk of experiencing postoperative bleeding in patients undergoing dental extractions or minor oral surgery who continue using antiplatelet therapy Academic Article
-
Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis Academic Article
-
Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study Academic Article